Filter Results :

Your search for inhibitors returned 519 reports

Sort by


Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

06 Jan 2017  |  Published by:  MarketsandMarkets
The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.  In this report, the immunotherapy drugs market is segmented on the basis of type of drugs, therapy area...

$ 5,650.00

Read More

Corrosion Inhibitors: Global Markets

02 Jan 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for corrosion inhibitors is expected to reach $8.7 billion by 2021 from $6.9 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.6% from 2016 through 2021.This report provides:-An overview of the global markets for corrosive inhibitors-Analyses of global market tre...

$ 6,650.00

Read More

20s Proteasome Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
20s Proteasome Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 20s Proteasome Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, I...

$ 1,250.00

Read More

30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
30S Ribosomal Subunit (30S RNA) Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 30S Ribosomal Subunit (30S RNA) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development in...

$ 1,250.00

Read More

50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
50S Ribosomal Subunit (50S RNA) Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 50S Ribosomal Subunit (50S RNA) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development in...

$ 1,250.00

Read More

5-Alpha Reductase Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
5-Alpha Reductase Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 5-Alpha Reductase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
5-Lipoxygenase Activating Protein (FLAP) Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 5-Lipoxygenase Activating Protein (FLAP) Inhibitors. The DelveInsights Report covers the product profiles in various stages...

$ 1,250.00

Read More

5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors) -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors)-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the 5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors). The DelveInsights Report covers the prod...

$ 1,250.00

Read More

Activin Receptor-Like Kinase 1 (ALK1) Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Activin Receptor-Like Kinase 1 (ALK1) Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Activin Receptor-Like Kinase 1 (ALK1) Inhibitors. The DelveInsights Report covers the product profiles in various stages of de...

$ 1,250.00

Read More

Adrenergic Uptake Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Adrenergic Uptake Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Adrenergic Uptake Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

Aggrecanase Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Aggrecanase Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Aggrecanase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Ph...

$ 1,250.00

Read More

Akt1 Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Akt1 Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Akt1 Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase I...

$ 1,250.00

Read More

Akt2 Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Akt2 Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Akt2 Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase I...

$ 1,250.00

Read More

Akt3 Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Akt3 Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Akt3 Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase I...

$ 1,250.00

Read More

Aldose Reductase Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Aldose Reductase Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Aldose Reductase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinica...

$ 1,250.00

Read More
Total 519 records.